Roivant Sciences Ltd. (ROIV)
NASDAQ·Healthcare·Biotechnology
$39.43
-0.19%
Mkt Cap $29.49B
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (28 analysts)
$37.17
Range $30.00 – $42.00
Implied Upside
-5.7%
Consensus $37.17 vs current $39.43
NASDAQ·Healthcare·Biotechnology
$39.43
-0.19%
Mkt Cap $29.49B
Buy
13
Hold
0
Sell
0
Price Target (28 analysts)
$37.17
Range $30.00 – $42.00
-5.7%
Consensus $37.17 vs current $39.43